Literature DB >> 30666591

From Data Silos to Standardized, Linked, and FAIR Data for Pharmacovigilance: Current Advances and Challenges with Observational Healthcare Data.

Vassilis Koutkias1.   

Abstract

Mesh：

Year:  2019        PMID： 30666591     DOI： 10.1007/s40264-018-00793-z

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  27 in total

1.  Toward a national framework for the secondary use of health data: an American Medical Informatics Association White Paper.

Authors:  Charles Safran; Meryl Bloomrosen; W Edward Hammond; Steven Labkoff; Suzanne Markel-Fox; Paul C Tang; Don E Detmer
Journal:  J Am Med Inform Assoc       Date:  2006-10-31       Impact factor: 4.497

2.  How well do various health outcome definitions identify appropriate cases in observational studies?

Authors:  Richard A Hansen; Michael D Gray; Brent I Fox; Joshua C Hollingsworth; Juan Gao; Peng Zeng
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

3.  Development of a Controlled Vocabulary-Based Adverse Drug Reaction Signal Dictionary for Multicenter Electronic Health Record-Based Pharmacovigilance.

Authors:  Suehyun Lee; Jongsoo Han; Rae Woong Park; Grace Juyun Kim; John Hoon Rim; Jooyoung Cho; Kye Hwa Lee; Jisan Lee; Sujeong Kim; Ju Han Kim
Journal:  Drug Saf       Date:  2019-05       Impact factor: 5.606

Review 4.  Defining a reference set to support methodological research in drug safety.

Authors:  Patrick B Ryan; Martijn J Schuemie; Emily Welebob; Jon Duke; Sarah Valentine; Abraham G Hartzema
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

5.  International prevalence of adverse drug events in hospitals: an analysis of routine data from England, Germany, and the USA.

Authors:  Jürgen Stausberg
Journal:  BMC Health Serv Res       Date:  2014-03-13       Impact factor: 2.655

6.  Pediatric drug safety signal detection: a new drug-event reference set for performance testing of data-mining methods and systems.

Authors:  Osemeke U Osokogu; Federica Fregonese; Carmen Ferrajolo; Katia Verhamme; Sandra de Bie; Geert 't Jong; Mariana Catapano; Daniel Weibel; Florentia Kaguelidou; Wichor M Bramer; Yingfen Hsia; Ian C K Wong; Madlen Gazarian; Jan Bonhoeffer; Miriam Sturkenboom
Journal:  Drug Saf       Date:  2015-02       Impact factor: 5.606

7.  If these data could talk.

Authors:  Thomas Pasquier; Matthew K Lau; Ana Trisovic; Emery R Boose; Ben Couturier; Mercè Crosas; Aaron M Ellison; Valerie Gibson; Chris R Jones; Margo Seltzer
Journal:  Sci Data       Date:  2017-09-05       Impact factor: 6.444

8.  Large-scale adverse effects related to treatment evidence standardization (LAERTES): an open scalable system for linking pharmacovigilance evidence sources with clinical data.

Authors: 
Journal:  J Biomed Semantics       Date:  2017-03-07

9.  Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data.

Authors:  Jenna M Reps; Martijn J Schuemie; Marc A Suchard; Patrick B Ryan; Peter R Rijnbeek
Journal:  J Am Med Inform Assoc       Date:  2018-08-01       Impact factor: 4.497

10.  OpenPVSignal: Advancing Information Search, Sharing and Reuse on Pharmacovigilance Signals via FAIR Principles and Semantic Web Technologies.

Authors:  Pantelis Natsiavas; Richard D Boyce; Marie-Christine Jaulent; Vassilis Koutkias
Journal:  Front Pharmacol       Date:  2018-06-26       Impact factor: 5.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.